Intuitive Surgical (NASDAQ:ISRG) saw a mixed institutional landscape in the first quarter, highlighted by ABN AMRO Bank N.V. reducing its stake by 37.1% to 40,572 shares, worth approximately $18.9 million. Conversely, several smaller hedge funds including Riversedge Advisors LLC and Fiduciary Financial Group LLC increased...
Aaron Wealth Advisors LLC reduced its stake in Intuitive Surgical, Inc. (ISRG) by 21.9% in the first quarter, selling 1,377 shares and holding a remaining position of 4,903 shares valued at $2.26 million. This move was part of broader institutional activity where other firms like...
Intuitive Surgical, Inc. (ISRG) shares closed at $404.27, rising 1.14% despite a broader market decline where the S&P 500 and Nasdaq fell. However, the stock has underperformed over the past month, dropping 5.65% compared to gains in the Medical sector and losses in the wider...
Intuitive Surgical (ISRG) is highlighted as potentially undervalued following Q1 2026 data showing strong demand for its da Vinci 5 robotic surgery systems. The company placed 431 units in the quarter, representing a 17% year-over-year increase, driven by an upgrade cycle and higher leasing activity...
Intuitive Surgical (ISRG) reported a record first quarter with revenue climbing 23% to $2.77 billion and earnings per share of $2.50, significantly beating the analyst consensus of $2.08. Despite these strong fundamentals, shares dropped approximately 25% since the start of the year, trading around EUR...
Intuitive Surgical (ISRG) reported a strong capital placement performance in the first quarter of 2026, placing 431 da Vinci systems, a 17% year-over-year increase. This growth is largely driven by the accelerating adoption of the da Vinci 5 platform, which accounted for 232 placements. However,...
Intuitive Surgical (ISRG) is pivoting its growth strategy from developing new robotic platforms to building a digital ecosystem around its existing installed base of da Vinci systems. During the first quarter of 2026, management outlined a long-term plan leveraging surgical data, artificial intelligence, and connected...
Intuitive Surgical has promoted Taylor Patton to the role of Chief Commercial and Marketing Officer, effective July 1, succeeding Henry Charlton. Patton, a veteran executive with nearly two decades at the company, previously served as Global Senior Vice President of Endoluminal Business, where he led...
Goldman Sachs maintained its Buy rating on Intuitive Surgical (ISRG) but lowered its price target from $621 to $558 as of May 27, 2026. The firm noted that the MedTech sector is experiencing one of its weakest periods in 15-20 years due to performance and...
Intuitive Surgical (NASDAQ: ISRG) stock is currently trading near its 52-week lows, having declined approximately 30% from its early 2025 highs. Despite this drawdown, Wall Street analysts maintain an upbeat outlook with an average price target of $570, suggesting a potential recovery and gain of...
Intuitive Surgical (NASDAQ: ISRG) has announced a leadership change within its executive team, promoting Taylor Patton to the newly created role of Chief Commercial and Marketing Officer. Effective July 1, 2026, Patton will join the Executive Leadership Team, succeeding Henry Charlton in his previous title...
Intuitive Surgical (ISRG), Medtronic (MDT), and Stryker (SYK) are identified as key players where surgical robotics integrates with artificial intelligence capabilities. Intuitive Surgical reported Q1 FY26 non-GAAP EPS of $2.50, beating estimates by 18.66%, with revenue reaching $2.77 billion. The company's installed base of da...
Intuitive Surgical, Inc. (ISRG) is highlighted by Zacks Investment Research as a top growth stock candidate based on its proprietary scoring system which evaluates real growth prospects beyond traditional attributes. The report specifically assigns Intuitive Surgical a Growth Score of B and a Zacks Rank...
Intuitive Surgical (ISRG) is experiencing a period of valuation reassessment following a choppy recent stock price performance, with the share currently trading around $457.78. This marks a year-to-date decline of 18.54%, contrasting sharply with strong longer-term returns including a 51.04% three-year total shareholder return and...
Shares of Intuitive Surgical (NASDAQ: ISRG) have surged approximately 580% over the past decade, significantly outpacing the S&P 500's 240% gain during the same period. The company, known for its da Vinci surgical robot, operates as an industry pioneer with a substantial installed base of...
The article evaluates Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX) as beaten-down healthcare stocks that may offer opportunities for patient investors with approximately $1,000 to deploy. While both companies have delivered strong returns over the last decade, they have recently underperformed due to...
Intuitive Surgical shareholders have unanimously approved all four proposals at the company's 2026 Annual Meeting of Stockholders, held virtually on April 30, 2026, and elected a slate of 10 directors to serve until the 2027 annual meeting. The approved initiatives included an advisory vote on...
The provided article text contains no substantive financial information, news content, or data regarding Intuitive Surgical (ISRG). Instead, the text consists entirely of browser error messages indicating that the source website (www.stocktitan.net) could not be reached. The error logs include a timeout message stating "www.stocktitan.net...
Intuitive Surgical Inc. (ISRG) saw its shares decline by 2.75% to close at $453.83 on Wednesday, a performance that occurred against the backdrop of broader market weakness. The S&P 500 Index fell 0.04% to 7,135.95, while the Dow Jones Industrial Average dropped 0.57% to reach...
Intuitive Surgical (ISRG) shares declined by 3.3% as investors reacted to renewed scrutiny regarding a recent FDA early alert concerning specific surgical stapler reloads, alongside a broader valuation-driven pullback following the company's recent earnings release. Market participants also appear to be recalibrating their expectations for...
